October is Pregnancy and Infant Loss Awareness Month

Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A recent study explored the correlation between placental histologic types and recurrent preterm birth risk, shedding light on potential predictive factors for obstetric outcomes.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.

Discover how maternal vascular indices at 35 to 37 weeks' gestation offer crucial predictive value for identifying preeclampsia risk.